US Trump administration vaccine‑autism order

In early August 2026 the White House signaled it was preparing an executive order linking COVID‑19 vaccines to autism, a proposal driven by President Donald Trump and Health Secretary Robert F. Kennedy Jr. The administration announced new studies despite a long scientific consensus rejecting any causal link, and later clarified the order remained under consideration with timing uncertain.

By August 6 the White House was weighing a possible release of the order as early as the following week. Trump urged Kennedy to expand government research on childhood vaccine schedules and autism, while Kennedy reconstituted a federal autism panel and appointed members with ties to anti‑vaccine groups. A March court ruling had blocked key parts of his earlier effort to rewrite U.S. vaccine policy. White House spokesperson Kush Desai said the goal was to create “the best childhood vaccination schedule in the world,” emphasizing that the order would rely on “gold‑standard science.”

Advisers warned that emphasizing the vaccine‑autism issue could alienate voters and provoke backlash from the pharmaceutical industry, potentially harming Republican prospects ahead of the November midterms, but Trump continued to press for the order.